Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Autologous periodontal ligament stem cells (PDLSCs) are a specific population of mesenchymal stem cells harvested from a patient's own periodontal ligament, typically obtained from extracted teeth (such as third molars). These cells possess the unique capacity for self-renewal and multi-lineage differentiation into cementoblasts, osteoblasts, and fibroblasts. In clinical application, these cells are expanded ex vivo and then transplanted back into the patient's periodontal defects, often in combination with a scaffold or carrier like bovine-derived bone minerals or collagen matrices. Their primary therapeutic goal is the regeneration of the functional periodontal attachment apparatus—including new cementum, periodontal ligament, and alveolar bone—which is typically lost due to inflammatory diseases like periodontitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on autologous periodontal ligament stem cells.